This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
earnings-outlook: Archive
AGNT (AGNT) Reports Break-Even Earnings for Q2
by Zacks Equity Research
AGNT (AGNT) delivered earnings and revenue surprises of -100.00% and +2.93%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
AGNTPositive Net Change RMRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
American Financial Group (AFG) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
American Financial (AFG) delivered earnings and revenue surprises of +17.01% and +0.65%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
AFGNegative Net Change AIIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Accel Entertainment (ACEL) Lags Q2 Earnings Estimates
by Zacks Equity Research
Accel Entertainment (ACEL) delivered earnings and revenue surprises of -16.67% and +3.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
ACELPositive Net Change DKNGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Ardent Health, Inc. (ARDT) Q2 Earnings Lag Estimates
by Zacks Equity Research
Ardent Health, Inc. (ARDT) delivered earnings and revenue surprises of -29.41% and +1.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
ARDTNo Net Change GDRXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Angi (ANGI) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Angi (ANGI) delivered earnings and revenue surprises of -45.00% and -5.02%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
ANGIPositive Net Change PERIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
American Well (AMWL) delivered earnings and revenue surprises of +1.67% and +3.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
AMWLNegative Net Change OMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Amprius Technologies (AMPX) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Amprius (AMPX) delivered earnings and revenue surprises of 0.00% and +17.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
AMPXPositive Net Change KEELNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Astera Labs, Inc. (ALAB) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Astera Labs, Inc. (ALAB) delivered earnings and revenue surprises of +15.94% and +8.93%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
ALABPositive Net Change CEVAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
BlackLine (BL) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
BlackLine (BL) delivered earnings and revenue surprises of +7.02% and +0.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
BLPositive Net Change GTMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates
by Zacks Equity Research
Bio-Rad (BIO) delivered earnings and revenue surprises of +11.97% and -0.97%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
BIONegative Net Change ICUINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank